Ligand Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The page displays a free ESG analysis covering Ligand Pharmaceuticals Inc. The SDG rating for Ligand Pharmaceuticals Inc indicates its reporting of the UN SDGs. If you work at Ligand Pharmaceuticals Inc and you wish to licence your ESG rating, please get in touch.
Ligand Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 0.0 and governance score of 4.8.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Ligand Pharmaceuticals Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ligand Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ligand Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ligand Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ligand Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Ligand Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ligand Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ligand Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials. The company was incorporated in 1987 and is headquartered in Emeryville, California.